Martin Joyce
Director/Board Member chez ALDEYRA THERAPEUTICS, INC.
Fortune : 78 372 $ au 31/03/2024
Provenance du réseau au premier degré de Martin Joyce
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
| Public Company | Biotechnology | 21 | |
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA.
13
| Subsidiary | Medical Specialties | 13 |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
| Public Company | Medical Specialties | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Martin Joyce via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Secretary | |
| BOSTON SCIENTIFIC CORPORATION | Medical Distributors | Corporate Officer/Principal | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | President Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman General Counsel Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
FluGen, Inc.
 FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| ACERINOX S.A. | Steel | Director/Board Member | |
| GUERBET | Medical Specialties | Chief Executive Officer | |
| Boston University | College/University | Doctorate Degree Graduate Degree | |
| George Washington University | College/University | Undergraduate Degree Graduate Degree | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Clark University | College/University | Undergraduate Degree Undergraduate Degree | |
| Notre Dame College (Ohio) | College/University | Undergraduate Degree | |
| Springfield College | College/University | Graduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Graduate Degree | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| The State University of New York | College/University | Undergraduate Degree Undergraduate Degree | |
New England Aquarium Corp.
 New England Aquarium Corp. Agricultural Commodities/MillingProcess Industries New England Aquarium Corp. provides ocean exploration and marine conservation. The company was founded in 1969 and is headquartered in Boston, MA. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
| Leche Pascual Espana SL | Chairman | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| PHIO PHARMACEUTICALS CORP. | Biotechnology | President Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Human Resources Officer |
Statistiques
Internationale
| Etats-Unis | 44 |
| Espagne | 3 |
| Suisse | 2 |
| France | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Electronic Technology | 2 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 205 |
| Corporate Officer/Principal | 139 |
| Undergraduate Degree | 54 |
| President | 49 |
| Independent Dir/Board Member | 47 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jesse I. Treu | 38 |
| Asish Xavier | 33 |
| Marian L. Heard | 27 |
| Laura González Molero | 25 |
| Neal Walker | 24 |
| David J. Clark | 21 |
| Todd Brady | 20 |
| Gary Phillips | 20 |
| David Southwell | 19 |
| Fereydoun Firouz | 17 |
| Ben Bronstein | 16 |
| Nancy Miller-Rich | 15 |
| C. Boyd Clarke | 15 |
| Deborah Brown | 13 |
| Nancy Catarisano | 13 |
- Bourse
- Insiders
- Martin Joyce
- Connexions Sociétés
